TrialCancer2011

Phase 2 trial of rituximab and bortezomib in patients with relapsed or refractory mantle cell and follicular lymphoma.

Robert A Baiocchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.